Current UK practice in 177Lu-DOTATATE peptide receptor radionuclide therapy: a national survey of national health service centres

Key Points

• The survey aims to assess the variation in the implementation of [177Lu]-DOTATATE therapy across UK healthcare centres.
• Conducted a national survey among NHS centres
• Collected data on practical aspects of [177Lu]-DOTATATE therapy
• Analyzed free-text responses focusing on administration methods and incident learning
• Identified variability in practical aspects of [177Lu]-DOTATATE therapy
• Highlighted differing behavioural restrictions and risk assessment processes
• Showed potential benefits of shared learning among centres

Abstract